Business Wire

VA-THREATCONNECT

29.11.2021 17:33:05 CET | Business Wire | Press release

Share
Introducing ThreatConnect 6.4 - Improving Threat Intelligence Processes and SOC Metrics

ThreatConnect Inc.®, the leader in enabling a risk led and intelligence-driven security is announcing ThreatConnect 6.4, which introduces new capabilities that allow security operations and cyber threat intelligence (CTI) analysts to get useful context faster during investigations and to better measure team efficiencies.

ThreatConnect combines its Threat Intelligence Platform (TIP) and Security Orchestration and Automation platform (SOAR), creating a continuous feedback loop that helps make Intelligence-Driven Operations a reality. This latest product release builds upon the foundation of Intelligence-Driven Operations, empowering the workflow of threat intelligence and security operations teams individually and together.

The 6.4 release helps CTI and security operations center (SOC) teams get more context quickly, enabling faster investigations for both. CTI teams are enabled to more easily build and maintain a dynamic threat library, while updated dashboards allow SOC and IR leaders to accelerate the team’s efficiency. Three new features empower these capabilities:

  • Explore With CAL™ to better understand the complex relationships of threat indicators with a graph-based interface into our Collective Analytics Layer
  • Browser Extension V2 to build context around threats quickly and enhance your threat library
  • New Workflow Metrics to drive operational efficiencies, helping SOC teams learn how to optimize their tools, team processes, and automations

“With the release of ThreatConnect 6.4 we’re making good on our vision and promise to security operations and cyber threat intelligence teams to deliver capabilities that will allow them to make decisions faster with more relevant context,” said Andy Pendergast, co-founder and EVP of Product at ThreatConnect. “We’re enabling insights across teams to help them observe and orient to threats to their environment faster with intelligence, and then decide and act at scale with our robust orchestration and automation capabilities.”

Explore With CAL™

Threat Connect’s Collective Analytics Layer (CAL™) is an innovative architecture that distills billions of data points, offering immediate insights into the nature, prevalence, and relevance of a threat. CAL provides global context that leverages anonymously shared insights from ThreatConnect users, open-source intelligence, malware intelligence, and numerous other collections.

When conducting research and investigation into a particular threat, this new capability lets analysts pivot directly within the CAL™ dataset in an intuitive graph-based interface to understand the complex, infrastructure-based relationships and reputation that exist with a particular indicator of compromise (IOC).

Browser Extension

The latest iteration of the ThreatConnect Browser Extension moves beyond providing information about IOCs, enabling users with the capability to scan an online resource for potential threat actor names and their tools. This provides a desirable CAL™ enabled “Rosetta Stone” to match common threat actor aliases as well as insights on the entity regardless of which name is used.

When conducting research and investigation into a particular threat, analysts now have the ability to use multiple sources of threat intelligence to identify relevant pieces of information from any web-based resource. This is a critical capability when it comes to quickly understanding the severity level of the threat and allows one to add it to their threat library for future analysis and investigation efforts.

Workflow Metrics

Workflow metrics amplify the visibility of your security operations, providing important key performance indicators (KPIs) that help measure whether people, tools, and technologies are working together efficiently. 6.4 introduces enhancements to Workflow Metrics, providing deeper insights that show trends for detection and response across a period of time. SOC team leaders can also gain perspective on the distribution of team case assignments as well as how to best prioritize unassigned cases.

The addition of a dashboard visualization showing Mean Time to Detection (MTTD) and Mean Time to Respond (MTTR) over variable periods of time can help SOC leaders evaluate detection and response trends. New, simple to configure dashboard cards for active and unassigned cases lets team leads make more informed decisions when managing the workload of the team.

ThreatConnect’s risk-led, intelligence-driven approach reduces complexity, integrating processes and technologies to continually strengthen defenses, drive down risk, and revolutionize the way customers protect their organizations by turning intelligence into action.

About ThreatConnect

ThreatConnect, Inc. provides cybersecurity software that reduces complexity for everyone, makes decision-making easy by turning intelligence into action, and integrates processes and technologies to continually strengthen defenses and drive down risk. Designed by analysts but built for the entire team (security leadership, risk, security operations, threat intelligence, and incident response), ThreatConnect’s decision and operational support platform is the only solution available today with cyber risk quantification, intelligence, automation, analytics, and workflows in one. To learn more about our Cyber Risk Quantification, Threat Intelligence Platform (TIP) or Security Orchestration, Automation, and Response (SOAR) solutions visit www.ThreatConnect.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye